Search hospitals > Louisiana > New Orleans
Ochsner Clinic Foundation
Claim this profileNew Orleans, Louisiana 70121
Global Leader in Cancer
Global Leader in Coronavirus
Conducts research for Solid Tumors
Conducts research for Colorectal Cancer
Conducts research for Heart Failure
347 reported clinical trials
26 medical researchers
Summary
Ochsner Clinic Foundation is a medical facility located in New Orleans, Louisiana. This center is recognized for care of Cancer, Coronavirus, Solid Tumors, Colorectal Cancer, Heart Failure and other specialties. Ochsner Clinic Foundation is involved with conducting 347 clinical trials across 512 conditions. There are 26 research doctors associated with this hospital, such as Marc Matrana, MD, Jonathan Mizrahi, MD, Daniel Johnson, MD, and John Cole, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
FGFR3 positive
2Coronavirus
Global LeaderSARS-CoV-2
NAT
non-NAT
Top PIs
Marc Matrana, MDOchsner Medical Center Jefferson5 years of reported clinical research
Expert in Lung Cancer
Studies Non-Small Cell Lung Cancer
26 reported clinical trials
65 drugs studied
Jonathan Mizrahi, MDOchsner Medical Center Jefferson4 years of reported clinical research
Studies Pancreatic Cancer
Studies Colorectal Cancer
12 reported clinical trials
26 drugs studied
Daniel Johnson, MDOchsner Clinic Foundation7 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
11 reported clinical trials
27 drugs studied
John Cole, MDOchsner Medical Center Jefferson8 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
11 reported clinical trials
40 drugs studied
Clinical Trials running at Ochsner Clinic Foundation
Cancer
Multiple Sclerosis
Heart Failure
Liver Cancer
Age-Related Macular Degeneration
Colorectal Cancer
Parotid Gland Cancer
Solid Tumors
Bladder Cancer
Primary Lateral Sclerosis
NTX-1088 + Pembrolizumab
for Cancer
This trial tests NTX-1088, alone or with pembrolizumab, in patients with advanced solid cancers. NTX-1088 helps the immune system find and attack cancer cells, while pembrolizumab boosts the immune system's ability to fight cancer.
Recruiting2 awards Phase 1
RBS2418
for Cancer
This trial is testing a new drug called RBS2418, alone or with pembrolizumab, for patients with advanced tumors who haven't responded to other treatments. The drug works by boosting the body's natural defenses to better recognize and destroy cancer cells.
Recruiting1 award Phase 1
IMGS-001
for Advanced Cancer
The purpose of this Phase 1a/1b clinical trial is to test the safety of an investigational drug called IMGS-001 and to determine how well it can work in treating patients with advanced solid tumors that have come back or are not improving after receiving other drugs that are commonly used for their cancer. Phase 1a (Part 1) will test the safety of five different doses of IMGS-001 to use in further studies. Patients with cancer that have advanced or spread to other parts of the body following treatment with other available therapies will be treated in Part 1. Phase 1b (Part 2) will test two doses of IMGS-001 identified in Part 1 to further determine the safety and potential effectiveness in select cancer types.
Recruiting1 award Phase 126 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Ochsner Clinic Foundation?
Where is Ochsner Clinic Foundation located?
Who should I call to ask about financial aid or insurance network?
What insurance does Ochsner Clinic Foundation accept?
What awards or recognition has Ochsner Clinic Foundation received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.